Increased virus replication in mammalian cells by blocking intracellular innate defense responses
暂无分享,去创建一个
B. Berkhout | J. Haasnoot | M. Cornelissen | F. Zorgdrager | B Berkhout | W de Vries | J Haasnoot | J van der Velden | T van Montfort | F Zorgdrager | W Paxton | M Cornelissen | F van Kuppeveld | P de Haan | P. Haan | T. V. Montfort | F. V. Kuppeveld | W. Paxton | F. Kuppeveld | W. D. Vries | J. Velden | J. V. Velden | Ben Berkhout | Marion Cornelissen | Joost Haasnoot | William A. Paxton
[1] B. Berkhout,et al. Inhibition of virus replication by RNA interference. , 2003, Journal of biomedical science.
[2] K. Kok,et al. Human TRBP and PACT Directly Interact with Each Other and Associate with Dicer to Facilitate the Production of Small Interfering RNA* , 2007, Journal of Biological Chemistry.
[3] G. Sen,et al. PACT, a protein activator of the interferon‐induced protein kinase, PKR , 1998, The EMBO journal.
[4] Michael Karin,et al. Intracellular pattern recognition receptors in the host response , 2006, Nature.
[5] Khaled Machaca,et al. RNA interference is an antiviral defence mechanism in Caenorhabditis elegans , 2005, Nature.
[6] H. Klenk,et al. The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 , 2003, Journal of Virology.
[7] Stefano Volinia,et al. Interferon modulation of cellular microRNAs as an antiviral mechanism , 2007, Nature.
[8] L. Tsai,et al. BACE1 Suppression by RNA Interference in Primary Cortical Neurons* , 2004, Journal of Biological Chemistry.
[9] V. Kim,et al. The role of PACT in the RNA silencing pathway , 2006, The EMBO journal.
[10] T. Mak,et al. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. , 1995, Virology.
[11] Ravi Sachidanandam,et al. A germline-specific class of small RNAs binds mammalian Piwi proteins , 2006, Nature.
[12] H. Soifer,et al. A potential role for RNA interference in controlling the activity of the human LINE-1 retrotransposon , 2005, Nucleic acids research.
[13] K. Moelling,et al. Dicer is involved in protection against influenza A virus infection. , 2007, The Journal of general virology.
[14] K. Lundstrom. Biology and application of alphaviruses in gene therapy , 2005, Gene Therapy.
[15] G. Szittya,et al. Size Selective Recognition of siRNA by an RNA Silencing Suppressor , 2003, Cell.
[16] Shou-Wei Ding,et al. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] A. Fire,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.
[18] Donald B Kohn,et al. Lentiviral vectors ready for prime-time , 2007, Nature Biotechnology.
[19] B. Berkhout,et al. The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing , 2007, PLoS pathogens.
[20] Tariq M Rana,et al. Small RNAs: Regulators and guardians of the genome , 2007, Journal of cellular physiology.
[21] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[22] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[23] R. Krug,et al. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Saïb,et al. A Cellular MicroRNA Mediates Antiviral Defense in Human Cells , 2005, Science.
[25] R. Carthew,et al. Methods and Materials , 1956, Eco-Art Therapy in Practice.
[26] Xuemin Zhang,et al. Evidence that RNA silencing functions as an antiviral defense mechanism in fungi , 2007, Proceedings of the National Academy of Sciences.
[27] Erica Ollmann Saphire,et al. Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling , 2006, Journal of Virology.
[28] D. Valerio,et al. Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors. , 2001, Virology.
[29] D. Levy,et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. , 1998, Virology.
[30] Jialing Huang,et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes , 2007, Nature Medicine.
[31] S. Akira,et al. The role of Toll-like receptors in immune disorders , 2006, Expert opinion on biological therapy.
[32] Gene W Yeo,et al. RNA sequence analysis defines Dicer's role in mouse embryonic stem cells , 2007, Proceedings of the National Academy of Sciences.
[33] B. Berkhout,et al. Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA , 2006, Gene Therapy.
[34] P. Sinn,et al. Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors – design, biosafety, and production , 2005, Gene Therapy.
[35] K. Jeang,et al. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA‐dependent protein kinase PKR , 1997, The EMBO journal.
[36] S. Le,et al. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. , 2005, Immunity.
[37] Sanghyuk Lee,et al. MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.
[38] B. Berkhout,et al. RNA interference against viruses: strike and counterstrike , 2007, Nature Biotechnology.
[39] E. Bucher,et al. The influenza A virus NS1 protein binds small interfering RNAs and suppresses RNA silencing in plants. , 2004, The Journal of general virology.
[40] K. Ishii,et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.
[41] R. Silverman,et al. Small self-RNA generated by RNase L amplifies antiviral innate immunity , 2007, Nature.
[42] Yong‐jun Liu,et al. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. , 2005, Annual review of immunology.
[43] V. Volchkov,et al. The Ebola virus VP35 protein functions as a type I IFN antagonist. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] B. Williams,et al. HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. , 2000, Archives of biochemistry and biophysics.
[45] P. Zamore,et al. ATP Requirements and Small Interfering RNA Structure in the RNA Interference Pathway , 2001, Cell.
[46] D. McDonald,et al. Visualization of the intracellular behavior of HIV in living cells , 2002, The Journal of cell biology.
[47] A. Pasquinelli,et al. A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA , 2001, Science.
[48] Pascal Barbry,et al. Suppression of MicroRNA-Silencing Pathway by HIV-1 During Virus Replication , 2007, Science.
[49] J. Ruijter,et al. Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology , 2006, Retrovirology.
[50] S. Hammond,et al. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells , 2000, Nature.
[51] L. Stamatatos,et al. Antibody mediated protection of immunized macaques against pathogenic SHIV challenge , 2006, Retrovirology.
[52] K. Kasschau,et al. A Counterdefensive Strategy of Plant Viruses Suppression of Posttranscriptional Gene Silencing , 1998, Cell.